{"gene":"HEXIM1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2003,"finding":"HEXIM1 (MAQ1) inhibits P-TEFb (CDK9/cyclin T) kinase activity in a process that specifically requires 7SK snRNA to mediate the HEXIM1:P-TEFb interaction; 7SK binding alone is insufficient to inhibit P-TEFb, and P-TEFb dissociates from HEXIM1 and 7SK during stress response.","method":"In vivo and in vitro transcription assays, immunoprecipitation, mass spectrometry identification of complex components","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro and in vivo assays across two independent labs (PMID:14580347 and PMID:12832472), replicated","pmids":["14580347","12832472"],"is_preprint":false},{"year":2004,"finding":"HEXIM1 binds 7SK snRNA directly through a central arginine-rich RNA-binding motif (amino acids 152-155), and the HEXIM1 C-terminal domain (aa 181-359) directly binds P-TEFb; a conserved motif (aa 202-205) is required for P-TEFb binding and inhibition but not for 7SK recognition, establishing a sequential assembly model.","method":"In vitro reconstitution of 7SK-dependent HEXIM1-P-TEFb complex with purified proteins, yeast three-hybrid tests, gel-shift assays, GST pull-down, yeast two-hybrid, point mutagenesis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with purified components, multiple orthogonal methods, mutagenesis validation","pmids":["15201869"],"is_preprint":false},{"year":2004,"finding":"The first 18 amino acids within the NLS of HEXIM1 constitute an arginine-rich motif (resembling HIV-1 Tat TAR-binding domain) that is necessary and sufficient for 7SK binding in vivo and in vitro; this motif is essential for HEXIM1's inhibitory action on P-TEFb and RNA Pol II transcription.","method":"In vivo and in vitro 7SK binding assays, HEXIM1 deletion/substitution mutants, immunoprecipitation, in vitro kinase assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis combined with in vitro and in vivo binding assays, clear domain mapping","pmids":["15169877"],"is_preprint":false},{"year":2005,"finding":"The large inactive P-TEFb complex contains one 7SK molecule, a HEXIM1 dimer (mediated by a C-terminal coiled-coil region), and two P-TEFb molecules; CDK9 phosphorylated at Thr186 is required for P-TEFb recruitment to the 7SK/HEXIM complex; conserved residues Tyr271 and Phe208 in HEXIM1 are required for P-TEFb inhibition but not complex formation.","method":"Mutational analysis, glycerol gradient sedimentation, in vitro kinase assays, stoichiometry analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — comprehensive mutagenesis with multiple functional readouts, stoichiometric analysis","pmids":["15965233"],"is_preprint":false},{"year":2005,"finding":"HEXIM1 contains a stable C-terminal cyclin T-binding domain (TBD, residues 255-359) that forms a coiled-coil homodimer and directly binds the cyclin boxes of cyclin T1; HIV-1 Tat competes with HEXIM1 for cyclin T1 binding, displacing HEXIM1 from the P-TEFb complex.","method":"GST pull-down, analytical gel filtration, isothermal titration calorimetry, fluorescence spectroscopy, size exclusion chromatography, HeLa cell functional assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro biochemical reconstitution with multiple biophysical methods and mutagenesis","pmids":["15855166"],"is_preprint":false},{"year":2005,"finding":"HEXIM1's basic region contains two monopartite and two bipartite nuclear localization sequences; the arginine-rich motif within the basic region is essential for 7SK snRNA binding, P-TEFb binding, and transcription inhibition; the basic region interacts with adjacent acidic regions in the absence of RNA, and removal of negative charges causes HEXIM1 sequestration into the large complex and nuclear speckle localization.","method":"NLS-deletion mutagenesis, immunofluorescence, subnuclear localization studies, in vivo transcription assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (mutagenesis, localization, functional assays) in single study","pmids":["16362050"],"is_preprint":false},{"year":2005,"finding":"HEXIM1 forms oligomers (most likely dimers) mediated by its C-terminal coiled-coil region and by 7SK snRNA binding to the central basic region; mutations in the N-terminal part of the coiled-coil abrogate P-TEFb binding and inhibition; oligomerization via both the coiled-coil and basic regions is critical for inhibition of transcriptional elongation.","method":"Alanine mutagenesis of conserved leucines, RNase A digestion, co-immunoprecipitation, in vivo transcription assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis with functional validation, multiple orthogonal methods","pmids":["16377779"],"is_preprint":false},{"year":2005,"finding":"HEXIM1 and HEXIM2 can form stable homo- and hetero-oligomers (most likely dimers); HEXIM2 compensates functionally for HEXIM1 loss to maintain constant levels of 7SK/HEXIM-bound P-TEFb, demonstrating a tightly regulated cellular mechanism balancing active and inactive P-TEFb.","method":"Immunoprecipitation, glycerol gradient sedimentation, HEXIM1 knockdown/HEXIM2 compensation assays, in vivo transcription assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — replicated across two independent papers (PMID:15713661 and PMID:15713662) with clean knockdown and functional rescue","pmids":["15713661","15713662"],"is_preprint":false},{"year":2006,"finding":"Two structurally distinct RNA elements in 7SK—the distal segment of the 5' hairpin (G24-C48/G60-C87) and the apical region of the 3' hairpin (G302-C324)—independently recruit HEXIM1 and P-TEFb respectively; HEXIM1 binding to the 5' hairpin is a prerequisite for P-TEFb association with the 3' hairpin.","method":"In vivo RNA-protein binding assays, mutagenesis of 7SK elements, HeLa cell transcription assays, minimal regulatory RNA reconstitution","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — systematic mutagenesis of both RNA elements with functional validation in cells","pmids":["16382153"],"is_preprint":false},{"year":2007,"finding":"HEXIM1 directly contacts CDK9 at its activation segment (near the catalytic cleft); the conserved PYNT sequence (aa 202-205) of HEXIM1, specifically F208, cross-links to a Cdk9 peptide within the activation segment controlling access to the catalytic cleft, suggesting HEXIM1 inhibits P-TEFb by interfering with substrate binding to CDK9.","method":"Photo-cross-linking with photoreactive amino acids in live cells, cell extracts, and in vitro reconstituted complexes; mass spectrometry identification of cross-linked peptides","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — photo-cross-linking in multiple contexts (live cells, extracts, and in vitro reconstitution) with MS identification","pmids":["27791144"],"is_preprint":false},{"year":2007,"finding":"The solution structure of the HEXIM1 cyclin T-binding domain (TBD) reveals a parallel coiled-coil homodimer with a preceding alpha helix folding back onto the first coiled-coil unit; NMR titration, fluorescence, and immunoprecipitation identify the binding interface covering the first coiled-coil segment, with electrostatic interactions between an acidic patch on HEXIM1 and positive residues of cyclin T1 driving complex formation.","method":"NMR solution structure determination, NMR titration, fluorescence spectroscopy, immunoprecipitation, mutagenesis with transcription regulation assays in cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — NMR structure with functional mutagenesis validation, multiple orthogonal biophysical methods","pmids":["17724342"],"is_preprint":false},{"year":2007,"finding":"HIV-1 Tat prevents formation of and releases P-TEFb from the 7SK snRNP by directly displacing HEXIM1 from cyclin T1 through high-affinity Tat-cyclin T1 interaction; in vitro, Tat competes with HEXIM1 for 7SK binding and can release P-TEFb from preformed P-TEFb-HEXIM1-7SK complex; primary blood lymphocytes show reduced 7SK snRNP upon HIV-1 infection.","method":"In vitro competition assays with purified proteins, immunoprecipitation in vivo, glycerol gradient sedimentation, primary cell analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution plus in vivo validation across multiple cell types, replicated with PMID:17576689","pmids":["17341462","17576689"],"is_preprint":false},{"year":2007,"finding":"HMBA activates PI3K/Akt, leading to phosphorylation of HEXIM1, which causes release of active P-TEFb from the HEXIM1/7SK snRNP complex; a phosphorylation-resistant HEXIM1 mutant blocks HMBA-induced P-TEFb release and HIV transcription activation.","method":"PI3K/Akt pathway inhibitors, phosphorylation assays, glycerol gradient sedimentation, chromatin immunoprecipitation, HEXIM1 phosphorylation mutants","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 — pathway inhibitors plus dominant-negative mutant validation with specific HIV transcription readout","pmids":["17937499"],"is_preprint":false},{"year":2008,"finding":"LARP7 is a stable component of the 7SK snRNP while HEXIM1 and P-TEFb are reversibly associated; immunodepletion of LARP7 depletes most 7SK RNA regardless of HEXIM1 or P-TEFb presence; LARP7 knockdown decreases steady-state 7SK levels and increases free P-TEFb.","method":"Glycerol gradient sedimentation, immunodepletion, siRNA knockdown, Tat transactivation assays","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — immunodepletion and siRNA with multiple functional readouts, identifies stable vs. reversible complex components","pmids":["18281698"],"is_preprint":false},{"year":2008,"finding":"Nucleophosmin (NPM) binds HEXIM1 in vitro and in vivo and acts as a negative regulator of HEXIM1; NPM overexpression causes proteasome-mediated degradation of HEXIM1 leading to P-TEFb activation; cytoplasmic NPMc+ mutant (found in AML) sequesters HEXIM1 in the cytoplasm, increasing RNA Pol II transcription.","method":"Co-immunoprecipitation, GST pull-down, siRNA knockdown, overexpression, subcellular fractionation, immunofluorescence, proteasome inhibitor experiments","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus pull-down, functional rescue/knockdown with defined mechanistic readouts","pmids":["18371977"],"is_preprint":false},{"year":2007,"finding":"hnRNPs A1, A2, Q, and R associate with 7SK RNA; their association increases when P-TEFb-HEXIM1-7SK is dissociated following transcription inhibition or HEXIM1 knockdown; knockdown of hnRNPs A1/A2 attenuates transcription-dependent dissociation of P-TEFb-HEXIM1-7SK complexes, implicating hnRNP-7SK interactions in P-TEFb activation.","method":"Mass spectrometry identification, immunoprecipitation, siRNA knockdown, glycerol gradient sedimentation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — MS identification followed by siRNA with clear functional consequence on P-TEFb equilibrium","pmids":["17709395"],"is_preprint":false},{"year":2010,"finding":"Release of P-TEFb from the 7SK snRNP by HIV-1 Tat or cellular activator Brd4 is accompanied by a major conformational change in 7SK RNA that blocks re-association of HEXIM1, suggesting that reincorporation of HEXIM1 into the 7SK snRNP is the regulated step of reassembly.","method":"In vitro P-TEFb release assay using immunoprecipitated 7SK snRNP (anti-LARP7), glycerol gradient sedimentation, RNA chemical modification (SHAPE/dimethyl sulfate probing)","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro release assay with purified snRNP plus RNA structure probing, mechanistic insight into reassembly","pmids":["20808803"],"is_preprint":false},{"year":2010,"finding":"HEXIM1 binds double-stranded RNA in a sequence-independent manner; upon dsRNA binding, a large conformational change occurs in HEXIM1 that allows recruitment and inhibition of P-TEFb; a significant fraction of HEXIM1 is cytoplasmic and both nuclear and cytoplasmic HEXIM1 is RNA-associated; HEXIM1 co-precipitates with miR-16 but not U6 or U2 snRNAs.","method":"In vitro RNA competition assays, subcellular fractionation, immunofluorescence, immunoprecipitation with RT-PCR","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — clean in vitro demonstration plus in vivo localization, single study","pmids":["17395637"],"is_preprint":false},{"year":2010,"finding":"NMR and biochemical analysis show that a repeated GAUC motif in the upper part of the 5' hairpin of 7SK is essential for specific HEXIM1 recognition; binding of the HEXIM1 arginine-rich motif (ARM) peptide induces opening of the GAUC motif and stabilization of an internal loop; a conserved proline-serine sequence in the ARM is essential for binding specificity and RNA conformational change.","method":"NMR spectroscopy, gel-shift assays, mutagenesis of 7SK and HEXIM1 ARM peptide","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — NMR structural data with biochemical validation and mutagenesis","pmids":["20675720"],"is_preprint":false},{"year":2009,"finding":"Photo-cross-linking identifies U30 of 7SK RNA as contacting HEXIM1 amino acids 210-220 in both a minimal RNA-binding site and a fully reconstituted 7SK/HEXIM1/P-TEFb complex; a minimal 7SK hairpin (nucleotides 24-87) can bind specifically to HEXIM1 in vivo.","method":"4-thioU photo-cross-linking, mass spectrometry, in vivo HEXIM1 binding assays","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — direct RNA-protein contact identification via photo-cross-linking in reconstituted complex and in vivo","pmids":["19244621"],"is_preprint":false},{"year":2009,"finding":"Cyclin T1 preferentially binds HEXIM1 and cyclin T2 preferentially binds HEXIM2 (higher affinities measured by ITC); importin alpha binds HEXIM1 and HEXIM2 to support nuclear import of cyclin T; the 7SK snRNA 5' hairpin (nucleotides 23-88) binds Cyclin T1-HEXIM1 with Kd <0.3 µM.","method":"Isothermal titration calorimetry, electrophoretic mobility shift assays, radioactively labelled 7SK snRNA","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — quantitative biophysical measurements with purified proteins and RNA","pmids":["19883659"],"is_preprint":false},{"year":2012,"finding":"PKC phosphorylates HEXIM1 at serine 158 (S158); phosphorylated HEXIM1 neither binds 7SK snRNA nor inhibits P-TEFb; phorbol esters, T cell antigen receptor engagement, and constitutively active PKCθ all inhibit 7SK snRNP formation and increase P-TEFb-dependent transcription through this mechanism; phosphorylation-resistant HEXIM1 (S158A) blocks these effects.","method":"In vitro phosphorylation assay, phosphorylation-resistant mutants, immunoprecipitation, T cell activation assays, glycerol gradient sedimentation","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro kinase assay with site-directed mutagenesis, physiological stimuli validation in T cells","pmids":["22821562"],"is_preprint":false},{"year":2005,"finding":"HEXIM1 forms a distinct complex with glucocorticoid receptor (GR) independently of 7SK RNA, CDK9, or cyclin T1; the arginine-rich NLS of HEXIM1 directly associates with the ligand-binding domain of GR; HEXIM1 overexpression decreases ligand-dependent association between GR and the coactivator TIF2; disruption of 7SK blunted HEXIM1's negative effect on AhR-dependent but not GR-mediated transcription.","method":"Co-immunoprecipitation, adenovirus-mediated overexpression, siRNA knockdown, immunofluorescence, domain mapping","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, domain-specific interaction, RNA-independent mechanism validated by antisense","pmids":["15941832"],"is_preprint":false},{"year":2008,"finding":"HEXIM1 inhibits estrogen receptor alpha (ERα)-mediated transcription by bridging an ERα-P-TEFb interaction; increased HEXIM1 expression in MCF-7 cells and MMTV/HEXIM1 mice decreased estrogen-driven cyclin D1 expression and reduced ERα, P-TEFb, and S2P RNAPII recruitment to ERα-responsive gene promoters; HEXIM1 specifically decreased estrogen-induced P-TEFb activity.","method":"ChIP assays, MMTV/HEXIM1 transgenic mouse model, siRNA knockdown, mammary gland functional assays, in vitro kinase assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — ChIP showing reduced recruitment at target promoters, in vivo transgenic validation, knockdown rescue","pmids":["18757415"],"is_preprint":false},{"year":2017,"finding":"HEXIM1 forms a ribonuclear complex (HDP-RNP) with the lncRNA NEAT1, DNA-PK subunits (DNAPKc, Ku70, Ku80), and paraspeckle proteins (SFPQ, NONO, PSPC1, RBM14, MATRIN3); HEXIM1 binding to NEAT1 is required for HDP-RNP assembly; the HDP-RNP is required for innate immune response to foreign DNA via the cGAS-STING-IRF3 pathway; foreign DNA remodels HDP-RNP to release paraspeckle proteins and recruit STING, activating DNAPKc and IRF3.","method":"Immunoprecipitation, mass spectrometry, RNA sequencing, siRNA knockdown, cGAS-STING pathway activation assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — IP/MS complex identification combined with functional knockdown and pathway activation assays, multiple orthogonal methods","pmids":["28712728"],"is_preprint":false},{"year":2015,"finding":"PPM1G phosphatase directly binds 7SK RNA and HEXIM1 after P-TEFb has been released from the 7SK snRNP; this dual binding blocks P-TEFb reassembly onto the snRNP to sustain NF-κB-mediated transcription elongation; ATM kinase regulates PPM1G-7SK snRNP interaction through site-specific PPM1G phosphorylation.","method":"ChIP assays, in vitro binding assays (direct PPM1G-7SK and PPM1G-HEXIM1 binding), siRNA knockdown, ATM inhibition experiments","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — direct in vitro binding demonstrated, ChIP shows kinetic recruitment, ATM-dependent regulation validated","pmids":["26324325"],"is_preprint":false},{"year":2016,"finding":"Under nucleotide stress, HEXIM1 is induced to form an inhibitory complex with P-TEFb to inhibit elongation at tumorigenic genes in melanoma; HEXIM1 overexpression suppresses melanoma formation in zebrafish while HEXIM1 inactivation accelerates tumor onset; anti-tumorigenic RNAs bind to and are stabilized by HEXIM1 under nucleotide stress.","method":"Zebrafish melanoma model (gain- and loss-of-function), human melanoma cell knockdown, RNA immunoprecipitation, gene expression analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic model with in vitro mechanistic validation, multiple orthogonal approaches","pmids":["27058786"],"is_preprint":false},{"year":2014,"finding":"Release of P-TEFb from the 7SK snRNP leads to increased transcription specifically from a proximal (unannotated) HEXIM1 promoter, not the distal promoter; this involves poised RNA Pol II, and the superelongation complex subunits AFF4 and ELL2 are recruited to this proximal promoter after P-TEFb release and are required for its transcriptional effects, creating an autoregulatory feedback loop.","method":"ChIP-seq, luciferase reporter assays, P-TEFb-releasing compound treatments, siRNA knockdown of AFF4/ELL2","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — ChIP-seq plus functional reporter assays with knockdown validation, defines feedback mechanism","pmids":["24515107"],"is_preprint":false},{"year":2004,"finding":"CLP-1 (mouse HEXIM1 ortholog) gene knockout causes prenatal lethality with left ventricular hypertrophy and downregulation of HAND1; CLP-1 null fetal hearts show altered nuclear and myofibril morphologies and re-expression of hypertrophic contractile genes.","method":"Gene knockout in mice, electron microscopy, Northern blot, cardiac phenotype analysis","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cardiac phenotype and molecular markers","pmids":["15172687"],"is_preprint":false},{"year":2007,"finding":"Insertional mutation disrupting the HEXIM1 C-terminal region causes prenatal lethality with defects in coronary patterning, thin ventricular walls, decreased myocardial vascularization, increased apoptosis, decreased VEGF expression (a direct transcriptional target of HEXIM1), and decreased FGF9; HEXIM1 attenuates repressive effects of C/EBPα on VEGF gene transcription.","method":"Insertional gene mutation in mice, PECAM-1 staining, immunohistochemistry, qRT-PCR, ChIP","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic model with ChIP validation of direct transcriptional target relationship","pmids":["18079413"],"is_preprint":false},{"year":2007,"finding":"CLP-1 (HEXIM1) dissociates from P-TEFb complex under hypertrophic stimuli (mechanical stretch, endothelin-1, phenylephrine) in cardiomyocytes; this dissociation is blocked by JAK2 inhibitor AG490, placing JAK/STAT signaling upstream of CLP-1 release from P-TEFb during cardiac hypertrophy.","method":"Immunoprecipitation in primary cardiomyocytes, mechanical stretch assay, JAK2 inhibitor (AG490), immunofluorescence co-localization","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 — epistasis via pharmacological inhibition with defined hypertrophic stimuli, co-IP validation","pmids":["17459355"],"is_preprint":false},{"year":2012,"finding":"HEXIM1 acts as a positive regulator of p53 by interacting with p53 (C-terminal regions of both proteins required) and preventing HDM2-mediated ubiquitination of p53, thereby enhancing p53 protein stability and upregulating p53 target genes (Puma, p21); HEXIM1 knockdown inhibits p53 induction and prevents cell cycle arrest caused by p53.","method":"Co-immunoprecipitation, ubiquitination assay, siRNA knockdown, overexpression, cell cycle analysis, target gene expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — direct protein interaction with domain mapping, ubiquitination assay with knockdown/rescue, multiple cancer cell lines","pmids":["22948151"],"is_preprint":false},{"year":2018,"finding":"BET inhibition (BRD4 inhibition) releases P-TEFb from its inhibitor HEXIM1, causing a rapid overall increase in RNA synthesis that promotes transcription-replication conflicts; HEXIM1 and RAD51 both promote BET inhibitor-induced fork slowing but prevent a DNA damage response at these conflicts.","method":"siRNA knockdown of HEXIM1, DNA fiber assays for fork speed, γH2AX assays for DNA damage, RAD51 foci analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — specific HEXIM1 knockdown with defined replication stress phenotype, epistasis with RAD51","pmids":["30463005"],"is_preprint":false},{"year":2019,"finding":"The histone demethylase KDM5B directly represses HEXIM1 expression by occupying the HEXIM1 promoter (H3K4me3/2 demethylation); RNAi knockdown of KDM5B or KDM5B inhibitors induce HEXIM1 expression, inhibit cancer cell proliferation, induce differentiation, and inhibit breast tumor metastasis.","method":"Chemical proteomics, biotin-NeutrAvidin pull-down, surface plasmon resonance, ChIP assays, shRNA knockdown, mouse metastasis model","journal":"Breast cancer research","confidence":"High","confidence_rationale":"Tier 2 — direct target identification by chemical proteomics confirmed by SPR, ChIP validation, in vivo model","pmids":["31805991"],"is_preprint":false},{"year":2016,"finding":"Hexim1 F208 (within the conserved PYNT/202PYNTTQFLM210 sequence) directly contacts the CDK9 activation segment controlling access to the catalytic cleft; reciprocally, Cdk9 W193 cross-links to Hexim1; this contact is proposed to block substrate binding to CDK9, explaining the mechanism of kinase inhibition.","method":"Site-specific incorporation of photoreactive amino acids, photo-cross-linking in live cells and in vitro, mass spectrometry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — direct contact identification by photo-cross-linking in three independent contexts (live cells, extracts, reconstituted complex)","pmids":["27791144"],"is_preprint":false}],"current_model":"HEXIM1 is an RNA-controlled inhibitor of P-TEFb (CDK9/cyclin T) that, upon binding to 7SK snRNA through its arginine-rich motif (triggering a conformational change), directly contacts both cyclin T1 (via its C-terminal coiled-coil homodimer domain) and the CDK9 catalytic cleft (via the PYNT sequence, blocking substrate access), thereby inactivating P-TEFb kinase activity and suppressing RNA Pol II transcription elongation; this inhibition is reversibly regulated by phosphorylation of HEXIM1 (by PKC at S158 or Akt) and by viral/cellular activators (HIV Tat, Brd4, PPM1G) that extract P-TEFb from the 7SK snRNP accompanied by a 7SK conformational change that prevents HEXIM1 re-association; beyond its role in the 7SK snRNP, HEXIM1 also directly engages glucocorticoid receptor, stabilizes p53 against HDM2-mediated ubiquitination, participates in a NEAT1 lncRNA-containing complex (HDP-RNP) that regulates innate immune signaling through cGAS-STING, and plays essential roles in cardiovascular development and cancer suppression."},"narrative":{"teleology":[{"year":2003,"claim":"Establishing HEXIM1 as the 7SK-dependent inhibitor of P-TEFb resolved the long-standing question of how the kinase is held inactive in the large nuclear complex and revealed that 7SK RNA is required not just for scaffolding but for enabling HEXIM1–P-TEFb interaction.","evidence":"In vivo/in vitro transcription assays, co-IP, and mass spectrometry in two independent studies","pmids":["14580347","12832472"],"confidence":"High","gaps":["Mechanism by which 7SK enables HEXIM1 binding to P-TEFb was unknown","Stoichiometry of the inhibitory complex was unresolved","Signals governing reversible assembly were undefined"]},{"year":2004,"claim":"Domain dissection established a sequential assembly model: the HEXIM1 arginine-rich motif first binds 7SK RNA, and this binding is a prerequisite that then allows the C-terminal domain (aa 181–359) to contact P-TEFb, with a conserved motif at aa 202–205 required specifically for kinase inhibition.","evidence":"In vitro reconstitution with purified proteins, yeast three-hybrid, gel-shift, GST pull-down, mutagenesis across multiple studies","pmids":["15201869","15169877"],"confidence":"High","gaps":["Structural basis for 7SK-induced conformational change in HEXIM1 was unknown","Exact contact surface on CDK9/cyclin T1 was not mapped"]},{"year":2004,"claim":"Mouse HEXIM1 knockout revealed an essential developmental role: loss of HEXIM1 causes prenatal lethality with cardiac hypertrophy and downregulation of HAND1, establishing HEXIM1 as indispensable for normal cardiovascular development.","evidence":"Gene knockout in mice with cardiac phenotype, electron microscopy, Northern blot","pmids":["15172687"],"confidence":"High","gaps":["Whether cardiac phenotype is solely due to deregulated P-TEFb was untested","HEXIM2 compensation in heart was not assessed"]},{"year":2005,"claim":"Determination that the large P-TEFb complex contains a HEXIM1 homodimer (via coiled-coil domain) bridging two P-TEFb molecules, and that HEXIM2 can functionally compensate for HEXIM1 loss, revealed the precise stoichiometry and redundancy safeguarding P-TEFb regulation.","evidence":"Glycerol gradient sedimentation, stoichiometry analysis, mutagenesis, HEXIM1 knockdown with HEXIM2 compensation assays","pmids":["15965233","15713661","15713662"],"confidence":"High","gaps":["Signals determining HEXIM1 vs. HEXIM2 usage were unclear","Whether heterodimers have distinct regulatory properties was untested"]},{"year":2005,"claim":"Biophysical characterization of the cyclin T-binding domain and the discovery that HIV-1 Tat competes with HEXIM1 for cyclin T1 binding defined the molecular basis for P-TEFb hijacking during HIV transcription activation.","evidence":"GST pull-down, ITC, fluorescence spectroscopy, analytical gel filtration, HeLa functional assays","pmids":["15855166","15941832"],"confidence":"High","gaps":["Structural detail of the Tat–cyclin T1–HEXIM1 competition interface was lacking","Whether GR interaction competes with P-TEFb binding was not fully resolved"]},{"year":2005,"claim":"Identification of a HEXIM1–glucocorticoid receptor complex independent of 7SK/P-TEFb established that HEXIM1 has functions beyond P-TEFb inhibition, acting as a direct nuclear receptor coregulator.","evidence":"Co-IP, domain mapping, siRNA knockdown, antisense-mediated 7SK disruption","pmids":["15941832"],"confidence":"High","gaps":["Physiological significance of HEXIM1–GR interaction in glucocorticoid target tissues was not established","Mechanism by which HEXIM1 displaces TIF2 from GR was unknown"]},{"year":2006,"claim":"Mapping distinct 7SK RNA elements for HEXIM1 and P-TEFb binding (5' hairpin for HEXIM1, 3' hairpin for P-TEFb) established that HEXIM1 binding to the 5' element is a prerequisite for P-TEFb loading onto the 3' element, explaining hierarchical snRNP assembly.","evidence":"Systematic 7SK mutagenesis, in vivo RNA-protein binding assays, minimal RNA reconstitution","pmids":["16382153"],"confidence":"High","gaps":["Contributions of LARP7 and MePCE to this hierarchical assembly were unknown","Whether the two 7SK elements communicate allosterically was untested"]},{"year":2007,"claim":"The NMR structure of the HEXIM1 cyclin T-binding domain revealed a parallel coiled-coil homodimer with an electrostatic binding interface for cyclin T1, and photo-cross-linking showed that HEXIM1 F208 directly contacts the CDK9 activation segment, establishing a dual-contact inhibition mechanism blocking both cyclin T and CDK9 substrate access.","evidence":"NMR solution structure, NMR titration, fluorescence, mutagenesis; site-specific photo-cross-linking in live cells and reconstituted complexes with MS identification","pmids":["17724342","27791144"],"confidence":"High","gaps":["Full atomic-resolution structure of the entire 7SK–HEXIM1–P-TEFb complex was lacking","Whether HEXIM1 also contacts CDK9 outside the activation segment was unresolved"]},{"year":2007,"claim":"Demonstration that HIV-1 Tat directly displaces HEXIM1 from preformed 7SK snRNP in vitro and in primary lymphocytes, and that Akt-mediated HEXIM1 phosphorylation independently releases P-TEFb, established two distinct molecular routes for P-TEFb activation relevant to HIV latency reversal.","evidence":"In vitro competition with purified proteins, glycerol gradients, PI3K/Akt inhibitors, phosphorylation-resistant HEXIM1 mutants, primary cell analysis","pmids":["17341462","17576689","17937499"],"confidence":"High","gaps":["Specific Akt phosphorylation site on HEXIM1 was not mapped in this study","Relative contribution of Tat displacement vs. phosphorylation during actual HIV infection was unclear"]},{"year":2007,"claim":"Insertional mutagenesis confirmed HEXIM1's cardiac essentiality and identified VEGF as a direct transcriptional target, showing HEXIM1 attenuates C/EBPα-mediated repression of VEGF, linking P-TEFb regulation to coronary vascularization.","evidence":"Mouse insertional mutation, PECAM-1 staining, ChIP at VEGF promoter, qRT-PCR","pmids":["18079413"],"confidence":"High","gaps":["Whether HEXIM1 regulation of VEGF is P-TEFb-dependent or through the C/EBPα mechanism alone was unresolved"]},{"year":2007,"claim":"Discovery that hypertrophic stimuli trigger HEXIM1 dissociation from P-TEFb via JAK/STAT signaling in cardiomyocytes connected P-TEFb reactivation to pathological cardiac hypertrophy.","evidence":"Co-IP in primary cardiomyocytes, mechanical stretch, endothelin-1, JAK2 inhibitor AG490","pmids":["17459355"],"confidence":"High","gaps":["Direct JAK2 target (HEXIM1 itself or an intermediary) was not identified","Whether this mechanism operates in vivo during heart failure was untested"]},{"year":2008,"claim":"Identification of LARP7 as the constitutive 7SK snRNP scaffold, with HEXIM1 and P-TEFb as reversible components, clarified the dynamic architecture of the snRNP and explained how 7SK stability is maintained independently of P-TEFb occupancy.","evidence":"Immunodepletion, glycerol gradient sedimentation, siRNA knockdown, Tat transactivation assays","pmids":["18281698"],"confidence":"High","gaps":["MePCE's role relative to LARP7 in snRNP stability was not fully addressed","Whether HEXIM1 can exist as a stable 7SK-bound intermediate without P-TEFb in vivo was debated"]},{"year":2008,"claim":"Nucleophosmin (NPM) was identified as a negative regulator that binds HEXIM1 and promotes its proteasomal degradation; the AML-associated cytoplasmic NPMc+ mutant sequesters HEXIM1, providing a disease mechanism linking HEXIM1 inactivation to leukemogenesis.","evidence":"Reciprocal co-IP, GST pull-down, proteasome inhibitor rescue, subcellular fractionation with NPMc+ mutant","pmids":["18371977"],"confidence":"High","gaps":["E3 ubiquitin ligase responsible for NPM-induced HEXIM1 degradation was not identified","In vivo relevance in AML patient samples was not shown"]},{"year":2010,"claim":"NMR revealed that HEXIM1 ARM binding induces opening of the GAUC motif in 7SK's 5' hairpin, and that P-TEFb release by Tat/Brd4 causes a major 7SK conformational change blocking HEXIM1 re-association, establishing HEXIM1 reincorporation as the rate-limiting step of snRNP reassembly.","evidence":"NMR spectroscopy of 7SK–ARM complex, SHAPE/DMS probing of released 7SK, in vitro release assays from immunopurified snRNP","pmids":["20675720","20808803"],"confidence":"High","gaps":["Factor(s) responsible for resetting 7SK conformation to allow HEXIM1 rebinding were unknown","Whether the conformational switch operates identically for HEXIM2 was untested"]},{"year":2012,"claim":"PKC phosphorylation of HEXIM1 at S158 was shown to abolish 7SK binding and P-TEFb inhibition, defining a direct signaling mechanism for P-TEFb activation downstream of TCR engagement.","evidence":"In vitro kinase assay, S158A phospho-resistant mutant, T cell activation assays, glycerol gradients","pmids":["22821562"],"confidence":"High","gaps":["Whether other kinases also target S158 was not excluded","Phosphatase(s) reversing S158 phosphorylation were not identified"]},{"year":2012,"claim":"HEXIM1 was shown to stabilize p53 by directly binding its C-terminus and preventing HDM2-mediated ubiquitination, establishing a P-TEFb-independent tumor suppressor function.","evidence":"Co-IP, ubiquitination assays, siRNA knockdown, cell cycle analysis in multiple cancer cell lines","pmids":["22948151"],"confidence":"High","gaps":["Whether HEXIM1–p53 interaction occurs in the context of 7SK snRNP or free HEXIM1 was unclear","In vivo tumor suppression via p53 stabilization was not directly tested"]},{"year":2015,"claim":"PPM1G phosphatase was found to bind both 7SK and HEXIM1 after P-TEFb release, blocking snRNP reassembly to sustain NF-κB transcription elongation under ATM kinase control, revealing a regulated 'lock' on the disassembled state.","evidence":"Direct in vitro binding assays, ChIP kinetics, ATM inhibition experiments","pmids":["26324325"],"confidence":"High","gaps":["PPM1G's phosphatase substrates relevant to this locking mechanism were not identified","Whether PPM1G competes with HEXIM1 for the same 7SK binding site was unresolved"]},{"year":2016,"claim":"Nucleotide stress was shown to induce HEXIM1 to suppress transcription at tumorigenic loci; HEXIM1 overexpression suppressed melanoma in zebrafish while its loss accelerated tumor onset, providing direct genetic evidence for HEXIM1 as a tumor suppressor.","evidence":"Zebrafish gain/loss-of-function melanoma model, RNA immunoprecipitation, human melanoma cell knockdown","pmids":["27058786"],"confidence":"High","gaps":["Identity and mechanism of anti-tumorigenic RNAs stabilized by HEXIM1 were not fully characterized","Whether the tumor-suppressive effect requires P-TEFb inhibition specifically was not dissected"]},{"year":2017,"claim":"Discovery of the HDP-RNP complex (HEXIM1–NEAT1–DNA-PK–paraspeckle proteins) and its role in cGAS-STING-IRF3 innate immune signaling revealed a major P-TEFb-independent function: HEXIM1 scaffolds an RNA-dependent complex that senses foreign DNA and activates interferon responses.","evidence":"IP/MS, RNA-seq, siRNA knockdown, cGAS-STING pathway activation assays","pmids":["28712728"],"confidence":"High","gaps":["Whether HEXIM1's RNA-binding specificity for NEAT1 vs. 7SK determines partitioning between P-TEFb and HDP-RNP functions was unclear","Structural basis of HDP-RNP assembly was unknown"]},{"year":2019,"claim":"KDM5B was identified as a direct transcriptional repressor of HEXIM1 via H3K4 demethylation at its promoter; KDM5B inhibition upregulates HEXIM1 and suppresses breast tumor metastasis, defining an epigenetic input controlling HEXIM1 expression in cancer.","evidence":"Chemical proteomics, SPR, ChIP at HEXIM1 promoter, shRNA knockdown, mouse metastasis model","pmids":["31805991"],"confidence":"High","gaps":["Whether other KDM5 family members also regulate HEXIM1 was not tested","Therapeutic window of KDM5B inhibition via HEXIM1 induction was not defined"]},{"year":null,"claim":"Major unresolved questions include the full atomic structure of the 7SK–HEXIM1–P-TEFb ternary complex, the molecular basis for partitioning HEXIM1 between 7SK snRNP and HDP-RNP functions, the identity of E3 ligases controlling HEXIM1 turnover, and how P-TEFb-dependent and -independent tumor suppressor activities of HEXIM1 are coordinated in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of the full ternary inhibitory complex","Mechanism of HEXIM1 allocation between 7SK snRNP and NEAT1-based HDP-RNP is unknown","E3 ligase for HEXIM1 ubiquitination/degradation has not been identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,3,9,34]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[1,2,5,17,18,19]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[22,23,29]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,14,17]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[5,24]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[14,17]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,3,9,23,26,27]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[24,25]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[12,21,30]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,26,33]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[28,29]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[31]}],"complexes":["7SK snRNP","HDP-RNP"],"partners":["CDK9","CCNT1","HEXIM2","LARP7","NPM1","TP53","NR3C1","PPM1G"],"other_free_text":[]},"mechanistic_narrative":"HEXIM1 is a key negative regulator of transcription elongation that functions as the RNA-dependent inhibitor of the positive transcription elongation factor b (P-TEFb, CDK9/cyclin T). HEXIM1 binds 7SK snRNA through its arginine-rich motif at the 5' hairpin GAUC repeat, triggering a conformational change that enables its C-terminal coiled-coil homodimer domain to engage cyclin T1 and its conserved PYNT motif (F208) to contact the CDK9 activation segment, blocking substrate access to the catalytic cleft and inactivating P-TEFb kinase activity [PMID:14580347, PMID:15201869, PMID:27791144, PMID:17724342]. This inhibition is dynamically regulated by phosphorylation (PKC at S158 disrupts 7SK binding; Akt-mediated phosphorylation releases P-TEFb), by HIV-1 Tat competing for cyclin T1, and by PPM1G blocking snRNP reassembly through a 7SK conformational change, while HEXIM2 provides functional compensation to maintain cellular P-TEFb equilibrium [PMID:22821562, PMID:17937499, PMID:17341462, PMID:20808803, PMID:15713661]. Beyond P-TEFb regulation, HEXIM1 stabilizes p53 by preventing HDM2-mediated ubiquitination, forms a NEAT1 lncRNA-dependent HDP-RNP complex that activates innate immune signaling through the cGAS-STING-IRF3 pathway, directly modulates glucocorticoid and estrogen receptor-dependent transcription, and is essential for cardiovascular development, as mouse knockout causes prenatal lethality with cardiac hypertrophy and defective coronary vascularization [PMID:22948151, PMID:28712728, PMID:15941832, PMID:18757415, PMID:15172687, PMID:18079413]."},"prefetch_data":{"uniprot":{"accession":"O94992","full_name":"Protein HEXIM1","aliases":["Cardiac lineage protein 1","Estrogen down-regulated gene 1 protein","Hexamethylene bis-acetamide-inducible protein 1","Menage a quatre protein 1"],"length_aa":359,"mass_kda":40.6,"function":"Transcriptional regulator which functions as a general RNA polymerase II transcription inhibitor (PubMed:14580347, PubMed:15201869, PubMed:15713661). Core component of the 7SK RNP complex: in cooperation with 7SK snRNA sequesters P-TEFb in a large inactive 7SK snRNP complex preventing RNA polymerase II phosphorylation and subsequent transcriptional elongation (PubMed:12832472, PubMed:14580347, PubMed:15201869, PubMed:15713661). May also regulate NF-kappa-B, ESR1, NR3C1 and CIITA-dependent transcriptional activity (PubMed:15940264, PubMed:15941832, PubMed:17088550). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/O94992/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/HEXIM1","classification":"Not Classified","n_dependent_lines":345,"n_total_lines":1208,"dependency_fraction":0.2855960264900662},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CDK9","stoichiometry":10.0},{"gene":"LARP7","stoichiometry":10.0},{"gene":"CSNK2B","stoichiometry":0.2},{"gene":"DDOST","stoichiometry":0.2},{"gene":"DDX21","stoichiometry":0.2},{"gene":"SLC9A3R1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/HEXIM1","total_profiled":1310},"omim":[{"mim_id":"615695","title":"HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 2; HEXIM2","url":"https://www.omim.org/entry/615695"},{"mim_id":"612026","title":"La RIBONUCLEOPROTEIN 7, TRANSCRIPTIONAL REGULATOR; LARP7","url":"https://www.omim.org/entry/612026"},{"mim_id":"611478","title":"METHYLPHOSPHATE CAPPING ENZYME; MEPCE","url":"https://www.omim.org/entry/611478"},{"mim_id":"608749","title":"BROMODOMAIN-CONTAINING PROTEIN 4; BRD4","url":"https://www.omim.org/entry/608749"},{"mim_id":"607328","title":"HEXAMETHYLENE BIS ACETAMIDE-INDUCIBLE PROTEIN 1; HEXIM1","url":"https://www.omim.org/entry/607328"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/HEXIM1"},"hgnc":{"alias_symbol":["CLP-1","HIS1","MAQ1","EDG1"],"prev_symbol":[]},"alphafold":{"accession":"O94992","domains":[{"cath_id":"-","chopping":"166-202","consensus_level":"medium","plddt":89.8808,"start":166,"end":202},{"cath_id":"1.20.5","chopping":"290-349","consensus_level":"medium","plddt":92.6457,"start":290,"end":349}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O94992","model_url":"https://alphafold.ebi.ac.uk/files/AF-O94992-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O94992-F1-predicted_aligned_error_v6.png","plddt_mean":65.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=HEXIM1","jax_strain_url":"https://www.jax.org/strain/search?query=HEXIM1"},"sequence":{"accession":"O94992","fasta_url":"https://rest.uniprot.org/uniprotkb/O94992.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O94992/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O94992"}},"corpus_meta":[{"pmid":"11032855","id":"PMC_11032855","title":"Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.","date":"2000","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11032855","citation_count":977,"is_preprint":false},{"pmid":"9488656","id":"PMC_9488656","title":"Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1.","date":"1998","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/9488656","citation_count":853,"is_preprint":false},{"pmid":"9660876","id":"PMC_9660876","title":"Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival.","date":"1998","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9660876","citation_count":427,"is_preprint":false},{"pmid":"14580347","id":"PMC_14580347","title":"Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/14580347","citation_count":404,"is_preprint":false},{"pmid":"11230698","id":"PMC_11230698","title":"Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11230698","citation_count":369,"is_preprint":false},{"pmid":"10488065","id":"PMC_10488065","title":"Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10488065","citation_count":289,"is_preprint":false},{"pmid":"11094076","id":"PMC_11094076","title":"Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11094076","citation_count":275,"is_preprint":false},{"pmid":"15201869","id":"PMC_15201869","title":"Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.","date":"2004","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15201869","citation_count":266,"is_preprint":false},{"pmid":"11583630","id":"PMC_11583630","title":"Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis.","date":"2001","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/11583630","citation_count":264,"is_preprint":false},{"pmid":"11150298","id":"PMC_11150298","title":"Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11150298","citation_count":255,"is_preprint":false},{"pmid":"9765227","id":"PMC_9765227","title":"EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9765227","citation_count":245,"is_preprint":false},{"pmid":"9480864","id":"PMC_9480864","title":"Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1.","date":"1998","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/9480864","citation_count":233,"is_preprint":false},{"pmid":"10383399","id":"PMC_10383399","title":"Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10383399","citation_count":225,"is_preprint":false},{"pmid":"12832472","id":"PMC_12832472","title":"MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12832472","citation_count":211,"is_preprint":false},{"pmid":"18281698","id":"PMC_18281698","title":"LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18281698","citation_count":207,"is_preprint":false},{"pmid":"10794715","id":"PMC_10794715","title":"Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10794715","citation_count":197,"is_preprint":false},{"pmid":"28712728","id":"PMC_28712728","title":"HEXIM1 and NEAT1 Long Non-coding RNA Form a Multi-subunit Complex that Regulates DNA-Mediated Innate Immune Response.","date":"2017","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/28712728","citation_count":191,"is_preprint":false},{"pmid":"17937499","id":"PMC_17937499","title":"HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription.","date":"2007","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/17937499","citation_count":187,"is_preprint":false},{"pmid":"6300123","id":"PMC_6300123","title":"Repeated DNA sequences upstream from HIS1 also occur at several other co-regulated genes in Saccharomyces cerevisiae.","date":"1983","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6300123","citation_count":186,"is_preprint":false},{"pmid":"15965233","id":"PMC_15965233","title":"Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15965233","citation_count":183,"is_preprint":false},{"pmid":"10198065","id":"PMC_10198065","title":"Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1.","date":"1999","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/10198065","citation_count":169,"is_preprint":false},{"pmid":"17341462","id":"PMC_17341462","title":"Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17341462","citation_count":165,"is_preprint":false},{"pmid":"8626678","id":"PMC_8626678","title":"The inducible G protein-coupled receptor edg-1 signals via the G(i)/mitogen-activated protein kinase pathway.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626678","citation_count":153,"is_preprint":false},{"pmid":"11557736","id":"PMC_11557736","title":"Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration.","date":"2001","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/11557736","citation_count":147,"is_preprint":false},{"pmid":"10381367","id":"PMC_10381367","title":"EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10381367","citation_count":142,"is_preprint":false},{"pmid":"11726541","id":"PMC_11726541","title":"EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration.","date":"2001","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11726541","citation_count":140,"is_preprint":false},{"pmid":"10982820","id":"PMC_10982820","title":"Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10982820","citation_count":133,"is_preprint":false},{"pmid":"10921915","id":"PMC_10921915","title":"Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10921915","citation_count":133,"is_preprint":false},{"pmid":"17576689","id":"PMC_17576689","title":"Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17576689","citation_count":132,"is_preprint":false},{"pmid":"16530800","id":"PMC_16530800","title":"His1 and His2 are distantly related, spindle-shaped haloviruses belonging to the novel virus group, Salterprovirus.","date":"2006","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/16530800","citation_count":114,"is_preprint":false},{"pmid":"15169877","id":"PMC_15169877","title":"A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15169877","citation_count":113,"is_preprint":false},{"pmid":"2560175","id":"PMC_2560175","title":"Biological activities of des-His1[Glu9]glucagon amide, a glucagon antagonist.","date":"1989","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/2560175","citation_count":112,"is_preprint":false},{"pmid":"9705355","id":"PMC_9705355","title":"Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9705355","citation_count":107,"is_preprint":false},{"pmid":"16382153","id":"PMC_16382153","title":"Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and HEXIM1 binding.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16382153","citation_count":105,"is_preprint":false},{"pmid":"15713662","id":"PMC_15713662","title":"HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15713662","citation_count":102,"is_preprint":false},{"pmid":"15855166","id":"PMC_15855166","title":"Identification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15855166","citation_count":102,"is_preprint":false},{"pmid":"20808803","id":"PMC_20808803","title":"The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20808803","citation_count":94,"is_preprint":false},{"pmid":"17709395","id":"PMC_17709395","title":"The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17709395","citation_count":93,"is_preprint":false},{"pmid":"15713661","id":"PMC_15713661","title":"Compensatory contributions of HEXIM1 and HEXIM2 in maintaining the balance of active and inactive positive transcription elongation factor b complexes for control of transcription.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15713661","citation_count":89,"is_preprint":false},{"pmid":"11604399","id":"PMC_11604399","title":"A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11604399","citation_count":89,"is_preprint":false},{"pmid":"16362050","id":"PMC_16362050","title":"Interplay between 7SK snRNA and oppositely charged regions in HEXIM1 direct the inhibition of P-TEFb.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16362050","citation_count":89,"is_preprint":false},{"pmid":"22098666","id":"PMC_22098666","title":"Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.","date":"2011","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/22098666","citation_count":89,"is_preprint":false},{"pmid":"11549339","id":"PMC_11549339","title":"EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes.","date":"2001","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/11549339","citation_count":83,"is_preprint":false},{"pmid":"9765495","id":"PMC_9765495","title":"His1, an archaeal virus of the Fuselloviridae family that infects Haloarcula hispanica.","date":"1998","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/9765495","citation_count":82,"is_preprint":false},{"pmid":"2719677","id":"PMC_2719677","title":"Histatins, a family of salivary histidine-rich proteins, are encoded by at least two loci (HIS1 and HIS2).","date":"1989","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2719677","citation_count":77,"is_preprint":false},{"pmid":"11741892","id":"PMC_11741892","title":"Dual regulation of EDG1/S1P(1) receptor phosphorylation and internalization by protein kinase C and G-protein-coupled receptor kinase 2.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11741892","citation_count":76,"is_preprint":false},{"pmid":"11673450","id":"PMC_11673450","title":"Sphingosine 1-phosphate activates nuclear factor-kappa B through Edg receptors. Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11673450","citation_count":69,"is_preprint":false},{"pmid":"27058786","id":"PMC_27058786","title":"Stress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress Melanoma.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27058786","citation_count":66,"is_preprint":false},{"pmid":"24592384","id":"PMC_24592384","title":"Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer.","date":"2014","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/24592384","citation_count":65,"is_preprint":false},{"pmid":"9226368","id":"PMC_9226368","title":"The mouse gene for the inducible G-protein-coupled receptor edg-1.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9226368","citation_count":65,"is_preprint":false},{"pmid":"12087059","id":"PMC_12087059","title":"N-glycans of sphingosine 1-phosphate receptor Edg-1 regulate ligand-induced receptor internalization.","date":"2002","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12087059","citation_count":65,"is_preprint":false},{"pmid":"16377779","id":"PMC_16377779","title":"Oligomerization of HEXIM1 via 7SK snRNA and coiled-coil region directs the inhibition of P-TEFb.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/16377779","citation_count":62,"is_preprint":false},{"pmid":"10818441","id":"PMC_10818441","title":"Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors.","date":"2000","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10818441","citation_count":56,"is_preprint":false},{"pmid":"17724342","id":"PMC_17724342","title":"Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17724342","citation_count":55,"is_preprint":false},{"pmid":"15172687","id":"PMC_15172687","title":"Ablation of the CLP-1 gene leads to down-regulation of the HAND1 gene and abnormality of the left ventricle of the heart and fetal death.","date":"2004","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/15172687","citation_count":55,"is_preprint":false},{"pmid":"27903752","id":"PMC_27903752","title":"HEXIM1 as a Robust Pharmacodynamic Marker for Monitoring Target Engagement of BET Family Bromodomain Inhibitors in Tumors and Surrogate Tissues.","date":"2016","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/27903752","citation_count":54,"is_preprint":false},{"pmid":"15063151","id":"PMC_15063151","title":"Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.","date":"2004","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15063151","citation_count":51,"is_preprint":false},{"pmid":"18371977","id":"PMC_18371977","title":"Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18371977","citation_count":49,"is_preprint":false},{"pmid":"22821562","id":"PMC_22821562","title":"PKC phosphorylates HEXIM1 and regulates P-TEFb activity.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22821562","citation_count":48,"is_preprint":false},{"pmid":"24515107","id":"PMC_24515107","title":"Release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein (snRNP) activates hexamethylene bisacetamide-inducible protein (HEXIM1) transcription.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24515107","citation_count":48,"is_preprint":false},{"pmid":"17671421","id":"PMC_17671421","title":"HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophy.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17671421","citation_count":47,"is_preprint":false},{"pmid":"10971577","id":"PMC_10971577","title":"Expression and characterization of Edg-1 receptors in rat cardiomyocytes: calcium deregulation in response to sphingosine 1-phosphate.","date":"2000","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10971577","citation_count":47,"is_preprint":false},{"pmid":"19036707","id":"PMC_19036707","title":"beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.","date":"2008","source":"Journal of biomolecular screening","url":"https://pubmed.ncbi.nlm.nih.gov/19036707","citation_count":45,"is_preprint":false},{"pmid":"23163639","id":"PMC_23163639","title":"Modified coat protein forms the flexible spindle-shaped virion of haloarchaeal virus His1.","date":"2012","source":"Environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/23163639","citation_count":44,"is_preprint":false},{"pmid":"17395637","id":"PMC_17395637","title":"HEXIM1 is a promiscuous double-stranded RNA-binding protein and interacts with RNAs in addition to 7SK in cultured cells.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17395637","citation_count":43,"is_preprint":false},{"pmid":"10818438","id":"PMC_10818438","title":"Sphingosine-1-phosphate signaling via the EDG-1 family of G-protein-coupled receptors.","date":"2000","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10818438","citation_count":42,"is_preprint":false},{"pmid":"11146117","id":"PMC_11146117","title":"Differential roles of Edg-1 and Edg-5, sphingosine 1-phosphate receptors, in the signaling pathways in C6 glioma cells.","date":"2000","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11146117","citation_count":42,"is_preprint":false},{"pmid":"27791144","id":"PMC_27791144","title":"An evolutionary conserved Hexim1 peptide binds to the Cdk9 catalytic site to inhibit P-TEFb.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27791144","citation_count":42,"is_preprint":false},{"pmid":"30463005","id":"PMC_30463005","title":"BET Inhibition Induces HEXIM1- and RAD51-Dependent Conflicts between Transcription and Replication.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30463005","citation_count":41,"is_preprint":false},{"pmid":"26324325","id":"PMC_26324325","title":"PPM1G Binds 7SK RNA and Hexim1 To Block P-TEFb Assembly into the 7SK snRNP and Sustain Transcription Elongation.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26324325","citation_count":41,"is_preprint":false},{"pmid":"8336540","id":"PMC_8336540","title":"Nucleotide sequence analysis of the human salivary protein genes HIS1 and HIS2, and evolution of the STATH/HIS gene family.","date":"1993","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/8336540","citation_count":41,"is_preprint":false},{"pmid":"11709084","id":"PMC_11709084","title":"The sphingosine-1-phosphate receptor EDG-1 is essential for platelet-derived growth factor-induced cell motility.","date":"2001","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/11709084","citation_count":41,"is_preprint":false},{"pmid":"7489899","id":"PMC_7489899","title":"Cloning of the Candida albicans HIS1 gene by direct complementation of a C. albicans histidine auxotroph using an improved double-ARS shuttle vector.","date":"1995","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/7489899","citation_count":40,"is_preprint":false},{"pmid":"8114708","id":"PMC_8114708","title":"Retroviral insertions in the murine His-1 locus activate the expression of a novel RNA that lacks an extensive open reading frame.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8114708","citation_count":40,"is_preprint":false},{"pmid":"35474141","id":"PMC_35474141","title":"Linker histone variant HIS1-3 and WRKY1 oppositely regulate salt stress tolerance in Arabidopsis.","date":"2022","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/35474141","citation_count":39,"is_preprint":false},{"pmid":"15941832","id":"PMC_15941832","title":"HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15941832","citation_count":39,"is_preprint":false},{"pmid":"20675720","id":"PMC_20675720","title":"HEXIM1 targets a repeated GAUC motif in the riboregulator of transcription 7SK and promotes base pair rearrangements.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20675720","citation_count":38,"is_preprint":false},{"pmid":"20201073","id":"PMC_20201073","title":"T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20201073","citation_count":37,"is_preprint":false},{"pmid":"1682866","id":"PMC_1682866","title":"His-1 and His-2: identification and chromosomal mapping of two commonly rearranged sites of viral integration in a myeloid leukemia.","date":"1991","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1682866","citation_count":35,"is_preprint":false},{"pmid":"15992410","id":"PMC_15992410","title":"Inhibition of Tat activity by the HEXIM1 protein.","date":"2005","source":"Retrovirology","url":"https://pubmed.ncbi.nlm.nih.gov/15992410","citation_count":34,"is_preprint":false},{"pmid":"16222702","id":"PMC_16222702","title":"Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiation.","date":"2006","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16222702","citation_count":33,"is_preprint":false},{"pmid":"18079413","id":"PMC_18079413","title":"Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor.","date":"2007","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/18079413","citation_count":33,"is_preprint":false},{"pmid":"7959012","id":"PMC_7959012","title":"Cloning of the rat edg-1 immediate-early gene: expression pattern suggests diverse functions.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/7959012","citation_count":31,"is_preprint":false},{"pmid":"22964639","id":"PMC_22964639","title":"Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis.","date":"2012","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22964639","citation_count":30,"is_preprint":false},{"pmid":"18757415","id":"PMC_18757415","title":"HEXIM1 regulates 17beta-estradiol/estrogen receptor-alpha-mediated expression of cyclin D1 in mammary cells via modulation of P-TEFb.","date":"2008","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18757415","citation_count":30,"is_preprint":false},{"pmid":"15789348","id":"PMC_15789348","title":"Cloning and disruption of the Pichia pastoris ARG1, ARG2, ARG3, HIS1, HIS2, HIS5, HIS6 genes and their use as auxotrophic markers.","date":"2005","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15789348","citation_count":29,"is_preprint":false},{"pmid":"22948151","id":"PMC_22948151","title":"Identification of HEXIM1 as a positive regulator of p53.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22948151","citation_count":27,"is_preprint":false},{"pmid":"20453883","id":"PMC_20453883","title":"HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20453883","citation_count":27,"is_preprint":false},{"pmid":"12119119","id":"PMC_12119119","title":"Structure, expression, and functional characterization of the mouse CLP-1 gene.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12119119","citation_count":27,"is_preprint":false},{"pmid":"17459355","id":"PMC_17459355","title":"Pivotal role of cardiac lineage protein-1 (CLP-1) in transcriptional elongation factor P-TEFb complex formation in cardiac hypertrophy.","date":"2007","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/17459355","citation_count":27,"is_preprint":false},{"pmid":"19883659","id":"PMC_19883659","title":"Specificity of Hexim1 and Hexim2 complex formation with cyclin T1/T2, importin alpha and 7SK snRNA.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19883659","citation_count":26,"is_preprint":false},{"pmid":"22334704","id":"PMC_22334704","title":"CCR7/CCL19 controls expression of EDG-1 in T cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22334704","citation_count":26,"is_preprint":false},{"pmid":"31805991","id":"PMC_31805991","title":"Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells.","date":"2019","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/31805991","citation_count":25,"is_preprint":false},{"pmid":"8383321","id":"PMC_8383321","title":"Mechanism of action of des-His1-[Glu9]glucagon amide, a peptide antagonist of the glucagon receptor system.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8383321","citation_count":22,"is_preprint":false},{"pmid":"24189951","id":"PMC_24189951","title":"Marker effects and the nature of the recombination event at the his1 locus of Saccharomyces cerevisiae.","date":"1981","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24189951","citation_count":22,"is_preprint":false},{"pmid":"17314519","id":"PMC_17314519","title":"Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex.","date":"2007","source":"AIDS (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17314519","citation_count":21,"is_preprint":false},{"pmid":"22308025","id":"PMC_22308025","title":"Cardiac lineage protein-1 (CLP-1) regulates cardiac remodeling via transcriptional modulation of diverse hypertrophic and fibrotic responses and angiotensin II-transforming growth factor β (TGF-β1) signaling axis.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22308025","citation_count":21,"is_preprint":false},{"pmid":"29345523","id":"PMC_29345523","title":"Hexim1, an RNA-controlled protein hub.","date":"2018","source":"Transcription","url":"https://pubmed.ncbi.nlm.nih.gov/29345523","citation_count":20,"is_preprint":false},{"pmid":"19244621","id":"PMC_19244621","title":"U30 of 7SK RNA forms a specific photo-cross-link with Hexim1 in the context of both a minimal RNA-binding site and a fully reconstituted 7SK/Hexim1/P-TEFb ribonucleoprotein complex.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19244621","citation_count":20,"is_preprint":false},{"pmid":"20926576","id":"PMC_20926576","title":"Human T-lymphotropic virus type 1 Tax protein complexes with P-TEFb and competes for Brd4 and 7SK snRNP/HEXIM1 binding.","date":"2010","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/20926576","citation_count":20,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49420,"output_tokens":8810,"usd":0.140205},"stage2":{"model":"claude-opus-4-6","input_tokens":12618,"output_tokens":5273,"usd":0.292372},"total_usd":0.432577,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"HEXIM1 (MAQ1) inhibits P-TEFb (CDK9/cyclin T) kinase activity in a process that specifically requires 7SK snRNA to mediate the HEXIM1:P-TEFb interaction; 7SK binding alone is insufficient to inhibit P-TEFb, and P-TEFb dissociates from HEXIM1 and 7SK during stress response.\",\n      \"method\": \"In vivo and in vitro transcription assays, immunoprecipitation, mass spectrometry identification of complex components\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro and in vivo assays across two independent labs (PMID:14580347 and PMID:12832472), replicated\",\n      \"pmids\": [\"14580347\", \"12832472\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"HEXIM1 binds 7SK snRNA directly through a central arginine-rich RNA-binding motif (amino acids 152-155), and the HEXIM1 C-terminal domain (aa 181-359) directly binds P-TEFb; a conserved motif (aa 202-205) is required for P-TEFb binding and inhibition but not for 7SK recognition, establishing a sequential assembly model.\",\n      \"method\": \"In vitro reconstitution of 7SK-dependent HEXIM1-P-TEFb complex with purified proteins, yeast three-hybrid tests, gel-shift assays, GST pull-down, yeast two-hybrid, point mutagenesis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with purified components, multiple orthogonal methods, mutagenesis validation\",\n      \"pmids\": [\"15201869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The first 18 amino acids within the NLS of HEXIM1 constitute an arginine-rich motif (resembling HIV-1 Tat TAR-binding domain) that is necessary and sufficient for 7SK binding in vivo and in vitro; this motif is essential for HEXIM1's inhibitory action on P-TEFb and RNA Pol II transcription.\",\n      \"method\": \"In vivo and in vitro 7SK binding assays, HEXIM1 deletion/substitution mutants, immunoprecipitation, in vitro kinase assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis combined with in vitro and in vivo binding assays, clear domain mapping\",\n      \"pmids\": [\"15169877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The large inactive P-TEFb complex contains one 7SK molecule, a HEXIM1 dimer (mediated by a C-terminal coiled-coil region), and two P-TEFb molecules; CDK9 phosphorylated at Thr186 is required for P-TEFb recruitment to the 7SK/HEXIM complex; conserved residues Tyr271 and Phe208 in HEXIM1 are required for P-TEFb inhibition but not complex formation.\",\n      \"method\": \"Mutational analysis, glycerol gradient sedimentation, in vitro kinase assays, stoichiometry analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — comprehensive mutagenesis with multiple functional readouts, stoichiometric analysis\",\n      \"pmids\": [\"15965233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HEXIM1 contains a stable C-terminal cyclin T-binding domain (TBD, residues 255-359) that forms a coiled-coil homodimer and directly binds the cyclin boxes of cyclin T1; HIV-1 Tat competes with HEXIM1 for cyclin T1 binding, displacing HEXIM1 from the P-TEFb complex.\",\n      \"method\": \"GST pull-down, analytical gel filtration, isothermal titration calorimetry, fluorescence spectroscopy, size exclusion chromatography, HeLa cell functional assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro biochemical reconstitution with multiple biophysical methods and mutagenesis\",\n      \"pmids\": [\"15855166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HEXIM1's basic region contains two monopartite and two bipartite nuclear localization sequences; the arginine-rich motif within the basic region is essential for 7SK snRNA binding, P-TEFb binding, and transcription inhibition; the basic region interacts with adjacent acidic regions in the absence of RNA, and removal of negative charges causes HEXIM1 sequestration into the large complex and nuclear speckle localization.\",\n      \"method\": \"NLS-deletion mutagenesis, immunofluorescence, subnuclear localization studies, in vivo transcription assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (mutagenesis, localization, functional assays) in single study\",\n      \"pmids\": [\"16362050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HEXIM1 forms oligomers (most likely dimers) mediated by its C-terminal coiled-coil region and by 7SK snRNA binding to the central basic region; mutations in the N-terminal part of the coiled-coil abrogate P-TEFb binding and inhibition; oligomerization via both the coiled-coil and basic regions is critical for inhibition of transcriptional elongation.\",\n      \"method\": \"Alanine mutagenesis of conserved leucines, RNase A digestion, co-immunoprecipitation, in vivo transcription assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with functional validation, multiple orthogonal methods\",\n      \"pmids\": [\"16377779\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HEXIM1 and HEXIM2 can form stable homo- and hetero-oligomers (most likely dimers); HEXIM2 compensates functionally for HEXIM1 loss to maintain constant levels of 7SK/HEXIM-bound P-TEFb, demonstrating a tightly regulated cellular mechanism balancing active and inactive P-TEFb.\",\n      \"method\": \"Immunoprecipitation, glycerol gradient sedimentation, HEXIM1 knockdown/HEXIM2 compensation assays, in vivo transcription assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — replicated across two independent papers (PMID:15713661 and PMID:15713662) with clean knockdown and functional rescue\",\n      \"pmids\": [\"15713661\", \"15713662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Two structurally distinct RNA elements in 7SK—the distal segment of the 5' hairpin (G24-C48/G60-C87) and the apical region of the 3' hairpin (G302-C324)—independently recruit HEXIM1 and P-TEFb respectively; HEXIM1 binding to the 5' hairpin is a prerequisite for P-TEFb association with the 3' hairpin.\",\n      \"method\": \"In vivo RNA-protein binding assays, mutagenesis of 7SK elements, HeLa cell transcription assays, minimal regulatory RNA reconstitution\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — systematic mutagenesis of both RNA elements with functional validation in cells\",\n      \"pmids\": [\"16382153\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HEXIM1 directly contacts CDK9 at its activation segment (near the catalytic cleft); the conserved PYNT sequence (aa 202-205) of HEXIM1, specifically F208, cross-links to a Cdk9 peptide within the activation segment controlling access to the catalytic cleft, suggesting HEXIM1 inhibits P-TEFb by interfering with substrate binding to CDK9.\",\n      \"method\": \"Photo-cross-linking with photoreactive amino acids in live cells, cell extracts, and in vitro reconstituted complexes; mass spectrometry identification of cross-linked peptides\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — photo-cross-linking in multiple contexts (live cells, extracts, and in vitro reconstitution) with MS identification\",\n      \"pmids\": [\"27791144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The solution structure of the HEXIM1 cyclin T-binding domain (TBD) reveals a parallel coiled-coil homodimer with a preceding alpha helix folding back onto the first coiled-coil unit; NMR titration, fluorescence, and immunoprecipitation identify the binding interface covering the first coiled-coil segment, with electrostatic interactions between an acidic patch on HEXIM1 and positive residues of cyclin T1 driving complex formation.\",\n      \"method\": \"NMR solution structure determination, NMR titration, fluorescence spectroscopy, immunoprecipitation, mutagenesis with transcription regulation assays in cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structure with functional mutagenesis validation, multiple orthogonal biophysical methods\",\n      \"pmids\": [\"17724342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HIV-1 Tat prevents formation of and releases P-TEFb from the 7SK snRNP by directly displacing HEXIM1 from cyclin T1 through high-affinity Tat-cyclin T1 interaction; in vitro, Tat competes with HEXIM1 for 7SK binding and can release P-TEFb from preformed P-TEFb-HEXIM1-7SK complex; primary blood lymphocytes show reduced 7SK snRNP upon HIV-1 infection.\",\n      \"method\": \"In vitro competition assays with purified proteins, immunoprecipitation in vivo, glycerol gradient sedimentation, primary cell analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution plus in vivo validation across multiple cell types, replicated with PMID:17576689\",\n      \"pmids\": [\"17341462\", \"17576689\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"HMBA activates PI3K/Akt, leading to phosphorylation of HEXIM1, which causes release of active P-TEFb from the HEXIM1/7SK snRNP complex; a phosphorylation-resistant HEXIM1 mutant blocks HMBA-induced P-TEFb release and HIV transcription activation.\",\n      \"method\": \"PI3K/Akt pathway inhibitors, phosphorylation assays, glycerol gradient sedimentation, chromatin immunoprecipitation, HEXIM1 phosphorylation mutants\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pathway inhibitors plus dominant-negative mutant validation with specific HIV transcription readout\",\n      \"pmids\": [\"17937499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"LARP7 is a stable component of the 7SK snRNP while HEXIM1 and P-TEFb are reversibly associated; immunodepletion of LARP7 depletes most 7SK RNA regardless of HEXIM1 or P-TEFb presence; LARP7 knockdown decreases steady-state 7SK levels and increases free P-TEFb.\",\n      \"method\": \"Glycerol gradient sedimentation, immunodepletion, siRNA knockdown, Tat transactivation assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — immunodepletion and siRNA with multiple functional readouts, identifies stable vs. reversible complex components\",\n      \"pmids\": [\"18281698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Nucleophosmin (NPM) binds HEXIM1 in vitro and in vivo and acts as a negative regulator of HEXIM1; NPM overexpression causes proteasome-mediated degradation of HEXIM1 leading to P-TEFb activation; cytoplasmic NPMc+ mutant (found in AML) sequesters HEXIM1 in the cytoplasm, increasing RNA Pol II transcription.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, siRNA knockdown, overexpression, subcellular fractionation, immunofluorescence, proteasome inhibitor experiments\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus pull-down, functional rescue/knockdown with defined mechanistic readouts\",\n      \"pmids\": [\"18371977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"hnRNPs A1, A2, Q, and R associate with 7SK RNA; their association increases when P-TEFb-HEXIM1-7SK is dissociated following transcription inhibition or HEXIM1 knockdown; knockdown of hnRNPs A1/A2 attenuates transcription-dependent dissociation of P-TEFb-HEXIM1-7SK complexes, implicating hnRNP-7SK interactions in P-TEFb activation.\",\n      \"method\": \"Mass spectrometry identification, immunoprecipitation, siRNA knockdown, glycerol gradient sedimentation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — MS identification followed by siRNA with clear functional consequence on P-TEFb equilibrium\",\n      \"pmids\": [\"17709395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Release of P-TEFb from the 7SK snRNP by HIV-1 Tat or cellular activator Brd4 is accompanied by a major conformational change in 7SK RNA that blocks re-association of HEXIM1, suggesting that reincorporation of HEXIM1 into the 7SK snRNP is the regulated step of reassembly.\",\n      \"method\": \"In vitro P-TEFb release assay using immunoprecipitated 7SK snRNP (anti-LARP7), glycerol gradient sedimentation, RNA chemical modification (SHAPE/dimethyl sulfate probing)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro release assay with purified snRNP plus RNA structure probing, mechanistic insight into reassembly\",\n      \"pmids\": [\"20808803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"HEXIM1 binds double-stranded RNA in a sequence-independent manner; upon dsRNA binding, a large conformational change occurs in HEXIM1 that allows recruitment and inhibition of P-TEFb; a significant fraction of HEXIM1 is cytoplasmic and both nuclear and cytoplasmic HEXIM1 is RNA-associated; HEXIM1 co-precipitates with miR-16 but not U6 or U2 snRNAs.\",\n      \"method\": \"In vitro RNA competition assays, subcellular fractionation, immunofluorescence, immunoprecipitation with RT-PCR\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean in vitro demonstration plus in vivo localization, single study\",\n      \"pmids\": [\"17395637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NMR and biochemical analysis show that a repeated GAUC motif in the upper part of the 5' hairpin of 7SK is essential for specific HEXIM1 recognition; binding of the HEXIM1 arginine-rich motif (ARM) peptide induces opening of the GAUC motif and stabilization of an internal loop; a conserved proline-serine sequence in the ARM is essential for binding specificity and RNA conformational change.\",\n      \"method\": \"NMR spectroscopy, gel-shift assays, mutagenesis of 7SK and HEXIM1 ARM peptide\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structural data with biochemical validation and mutagenesis\",\n      \"pmids\": [\"20675720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Photo-cross-linking identifies U30 of 7SK RNA as contacting HEXIM1 amino acids 210-220 in both a minimal RNA-binding site and a fully reconstituted 7SK/HEXIM1/P-TEFb complex; a minimal 7SK hairpin (nucleotides 24-87) can bind specifically to HEXIM1 in vivo.\",\n      \"method\": \"4-thioU photo-cross-linking, mass spectrometry, in vivo HEXIM1 binding assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct RNA-protein contact identification via photo-cross-linking in reconstituted complex and in vivo\",\n      \"pmids\": [\"19244621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cyclin T1 preferentially binds HEXIM1 and cyclin T2 preferentially binds HEXIM2 (higher affinities measured by ITC); importin alpha binds HEXIM1 and HEXIM2 to support nuclear import of cyclin T; the 7SK snRNA 5' hairpin (nucleotides 23-88) binds Cyclin T1-HEXIM1 with Kd <0.3 µM.\",\n      \"method\": \"Isothermal titration calorimetry, electrophoretic mobility shift assays, radioactively labelled 7SK snRNA\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative biophysical measurements with purified proteins and RNA\",\n      \"pmids\": [\"19883659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKC phosphorylates HEXIM1 at serine 158 (S158); phosphorylated HEXIM1 neither binds 7SK snRNA nor inhibits P-TEFb; phorbol esters, T cell antigen receptor engagement, and constitutively active PKCθ all inhibit 7SK snRNP formation and increase P-TEFb-dependent transcription through this mechanism; phosphorylation-resistant HEXIM1 (S158A) blocks these effects.\",\n      \"method\": \"In vitro phosphorylation assay, phosphorylation-resistant mutants, immunoprecipitation, T cell activation assays, glycerol gradient sedimentation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro kinase assay with site-directed mutagenesis, physiological stimuli validation in T cells\",\n      \"pmids\": [\"22821562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"HEXIM1 forms a distinct complex with glucocorticoid receptor (GR) independently of 7SK RNA, CDK9, or cyclin T1; the arginine-rich NLS of HEXIM1 directly associates with the ligand-binding domain of GR; HEXIM1 overexpression decreases ligand-dependent association between GR and the coactivator TIF2; disruption of 7SK blunted HEXIM1's negative effect on AhR-dependent but not GR-mediated transcription.\",\n      \"method\": \"Co-immunoprecipitation, adenovirus-mediated overexpression, siRNA knockdown, immunofluorescence, domain mapping\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, domain-specific interaction, RNA-independent mechanism validated by antisense\",\n      \"pmids\": [\"15941832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"HEXIM1 inhibits estrogen receptor alpha (ERα)-mediated transcription by bridging an ERα-P-TEFb interaction; increased HEXIM1 expression in MCF-7 cells and MMTV/HEXIM1 mice decreased estrogen-driven cyclin D1 expression and reduced ERα, P-TEFb, and S2P RNAPII recruitment to ERα-responsive gene promoters; HEXIM1 specifically decreased estrogen-induced P-TEFb activity.\",\n      \"method\": \"ChIP assays, MMTV/HEXIM1 transgenic mouse model, siRNA knockdown, mammary gland functional assays, in vitro kinase assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP showing reduced recruitment at target promoters, in vivo transgenic validation, knockdown rescue\",\n      \"pmids\": [\"18757415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HEXIM1 forms a ribonuclear complex (HDP-RNP) with the lncRNA NEAT1, DNA-PK subunits (DNAPKc, Ku70, Ku80), and paraspeckle proteins (SFPQ, NONO, PSPC1, RBM14, MATRIN3); HEXIM1 binding to NEAT1 is required for HDP-RNP assembly; the HDP-RNP is required for innate immune response to foreign DNA via the cGAS-STING-IRF3 pathway; foreign DNA remodels HDP-RNP to release paraspeckle proteins and recruit STING, activating DNAPKc and IRF3.\",\n      \"method\": \"Immunoprecipitation, mass spectrometry, RNA sequencing, siRNA knockdown, cGAS-STING pathway activation assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — IP/MS complex identification combined with functional knockdown and pathway activation assays, multiple orthogonal methods\",\n      \"pmids\": [\"28712728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"PPM1G phosphatase directly binds 7SK RNA and HEXIM1 after P-TEFb has been released from the 7SK snRNP; this dual binding blocks P-TEFb reassembly onto the snRNP to sustain NF-κB-mediated transcription elongation; ATM kinase regulates PPM1G-7SK snRNP interaction through site-specific PPM1G phosphorylation.\",\n      \"method\": \"ChIP assays, in vitro binding assays (direct PPM1G-7SK and PPM1G-HEXIM1 binding), siRNA knockdown, ATM inhibition experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vitro binding demonstrated, ChIP shows kinetic recruitment, ATM-dependent regulation validated\",\n      \"pmids\": [\"26324325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Under nucleotide stress, HEXIM1 is induced to form an inhibitory complex with P-TEFb to inhibit elongation at tumorigenic genes in melanoma; HEXIM1 overexpression suppresses melanoma formation in zebrafish while HEXIM1 inactivation accelerates tumor onset; anti-tumorigenic RNAs bind to and are stabilized by HEXIM1 under nucleotide stress.\",\n      \"method\": \"Zebrafish melanoma model (gain- and loss-of-function), human melanoma cell knockdown, RNA immunoprecipitation, gene expression analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with in vitro mechanistic validation, multiple orthogonal approaches\",\n      \"pmids\": [\"27058786\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Release of P-TEFb from the 7SK snRNP leads to increased transcription specifically from a proximal (unannotated) HEXIM1 promoter, not the distal promoter; this involves poised RNA Pol II, and the superelongation complex subunits AFF4 and ELL2 are recruited to this proximal promoter after P-TEFb release and are required for its transcriptional effects, creating an autoregulatory feedback loop.\",\n      \"method\": \"ChIP-seq, luciferase reporter assays, P-TEFb-releasing compound treatments, siRNA knockdown of AFF4/ELL2\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-seq plus functional reporter assays with knockdown validation, defines feedback mechanism\",\n      \"pmids\": [\"24515107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CLP-1 (mouse HEXIM1 ortholog) gene knockout causes prenatal lethality with left ventricular hypertrophy and downregulation of HAND1; CLP-1 null fetal hearts show altered nuclear and myofibril morphologies and re-expression of hypertrophic contractile genes.\",\n      \"method\": \"Gene knockout in mice, electron microscopy, Northern blot, cardiac phenotype analysis\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cardiac phenotype and molecular markers\",\n      \"pmids\": [\"15172687\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Insertional mutation disrupting the HEXIM1 C-terminal region causes prenatal lethality with defects in coronary patterning, thin ventricular walls, decreased myocardial vascularization, increased apoptosis, decreased VEGF expression (a direct transcriptional target of HEXIM1), and decreased FGF9; HEXIM1 attenuates repressive effects of C/EBPα on VEGF gene transcription.\",\n      \"method\": \"Insertional gene mutation in mice, PECAM-1 staining, immunohistochemistry, qRT-PCR, ChIP\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model with ChIP validation of direct transcriptional target relationship\",\n      \"pmids\": [\"18079413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CLP-1 (HEXIM1) dissociates from P-TEFb complex under hypertrophic stimuli (mechanical stretch, endothelin-1, phenylephrine) in cardiomyocytes; this dissociation is blocked by JAK2 inhibitor AG490, placing JAK/STAT signaling upstream of CLP-1 release from P-TEFb during cardiac hypertrophy.\",\n      \"method\": \"Immunoprecipitation in primary cardiomyocytes, mechanical stretch assay, JAK2 inhibitor (AG490), immunofluorescence co-localization\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via pharmacological inhibition with defined hypertrophic stimuli, co-IP validation\",\n      \"pmids\": [\"17459355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"HEXIM1 acts as a positive regulator of p53 by interacting with p53 (C-terminal regions of both proteins required) and preventing HDM2-mediated ubiquitination of p53, thereby enhancing p53 protein stability and upregulating p53 target genes (Puma, p21); HEXIM1 knockdown inhibits p53 induction and prevents cell cycle arrest caused by p53.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, siRNA knockdown, overexpression, cell cycle analysis, target gene expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct protein interaction with domain mapping, ubiquitination assay with knockdown/rescue, multiple cancer cell lines\",\n      \"pmids\": [\"22948151\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BET inhibition (BRD4 inhibition) releases P-TEFb from its inhibitor HEXIM1, causing a rapid overall increase in RNA synthesis that promotes transcription-replication conflicts; HEXIM1 and RAD51 both promote BET inhibitor-induced fork slowing but prevent a DNA damage response at these conflicts.\",\n      \"method\": \"siRNA knockdown of HEXIM1, DNA fiber assays for fork speed, γH2AX assays for DNA damage, RAD51 foci analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — specific HEXIM1 knockdown with defined replication stress phenotype, epistasis with RAD51\",\n      \"pmids\": [\"30463005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The histone demethylase KDM5B directly represses HEXIM1 expression by occupying the HEXIM1 promoter (H3K4me3/2 demethylation); RNAi knockdown of KDM5B or KDM5B inhibitors induce HEXIM1 expression, inhibit cancer cell proliferation, induce differentiation, and inhibit breast tumor metastasis.\",\n      \"method\": \"Chemical proteomics, biotin-NeutrAvidin pull-down, surface plasmon resonance, ChIP assays, shRNA knockdown, mouse metastasis model\",\n      \"journal\": \"Breast cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct target identification by chemical proteomics confirmed by SPR, ChIP validation, in vivo model\",\n      \"pmids\": [\"31805991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hexim1 F208 (within the conserved PYNT/202PYNTTQFLM210 sequence) directly contacts the CDK9 activation segment controlling access to the catalytic cleft; reciprocally, Cdk9 W193 cross-links to Hexim1; this contact is proposed to block substrate binding to CDK9, explaining the mechanism of kinase inhibition.\",\n      \"method\": \"Site-specific incorporation of photoreactive amino acids, photo-cross-linking in live cells and in vitro, mass spectrometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct contact identification by photo-cross-linking in three independent contexts (live cells, extracts, reconstituted complex)\",\n      \"pmids\": [\"27791144\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"HEXIM1 is an RNA-controlled inhibitor of P-TEFb (CDK9/cyclin T) that, upon binding to 7SK snRNA through its arginine-rich motif (triggering a conformational change), directly contacts both cyclin T1 (via its C-terminal coiled-coil homodimer domain) and the CDK9 catalytic cleft (via the PYNT sequence, blocking substrate access), thereby inactivating P-TEFb kinase activity and suppressing RNA Pol II transcription elongation; this inhibition is reversibly regulated by phosphorylation of HEXIM1 (by PKC at S158 or Akt) and by viral/cellular activators (HIV Tat, Brd4, PPM1G) that extract P-TEFb from the 7SK snRNP accompanied by a 7SK conformational change that prevents HEXIM1 re-association; beyond its role in the 7SK snRNP, HEXIM1 also directly engages glucocorticoid receptor, stabilizes p53 against HDM2-mediated ubiquitination, participates in a NEAT1 lncRNA-containing complex (HDP-RNP) that regulates innate immune signaling through cGAS-STING, and plays essential roles in cardiovascular development and cancer suppression.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"HEXIM1 is a key negative regulator of transcription elongation that functions as the RNA-dependent inhibitor of the positive transcription elongation factor b (P-TEFb, CDK9/cyclin T). HEXIM1 binds 7SK snRNA through its arginine-rich motif at the 5' hairpin GAUC repeat, triggering a conformational change that enables its C-terminal coiled-coil homodimer domain to engage cyclin T1 and its conserved PYNT motif (F208) to contact the CDK9 activation segment, blocking substrate access to the catalytic cleft and inactivating P-TEFb kinase activity [PMID:14580347, PMID:15201869, PMID:27791144, PMID:17724342]. This inhibition is dynamically regulated by phosphorylation (PKC at S158 disrupts 7SK binding; Akt-mediated phosphorylation releases P-TEFb), by HIV-1 Tat competing for cyclin T1, and by PPM1G blocking snRNP reassembly through a 7SK conformational change, while HEXIM2 provides functional compensation to maintain cellular P-TEFb equilibrium [PMID:22821562, PMID:17937499, PMID:17341462, PMID:20808803, PMID:15713661]. Beyond P-TEFb regulation, HEXIM1 stabilizes p53 by preventing HDM2-mediated ubiquitination, forms a NEAT1 lncRNA-dependent HDP-RNP complex that activates innate immune signaling through the cGAS-STING-IRF3 pathway, directly modulates glucocorticoid and estrogen receptor-dependent transcription, and is essential for cardiovascular development, as mouse knockout causes prenatal lethality with cardiac hypertrophy and defective coronary vascularization [PMID:22948151, PMID:28712728, PMID:15941832, PMID:18757415, PMID:15172687, PMID:18079413].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing HEXIM1 as the 7SK-dependent inhibitor of P-TEFb resolved the long-standing question of how the kinase is held inactive in the large nuclear complex and revealed that 7SK RNA is required not just for scaffolding but for enabling HEXIM1–P-TEFb interaction.\",\n      \"evidence\": \"In vivo/in vitro transcription assays, co-IP, and mass spectrometry in two independent studies\",\n      \"pmids\": [\"14580347\", \"12832472\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which 7SK enables HEXIM1 binding to P-TEFb was unknown\", \"Stoichiometry of the inhibitory complex was unresolved\", \"Signals governing reversible assembly were undefined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Domain dissection established a sequential assembly model: the HEXIM1 arginine-rich motif first binds 7SK RNA, and this binding is a prerequisite that then allows the C-terminal domain (aa 181–359) to contact P-TEFb, with a conserved motif at aa 202–205 required specifically for kinase inhibition.\",\n      \"evidence\": \"In vitro reconstitution with purified proteins, yeast three-hybrid, gel-shift, GST pull-down, mutagenesis across multiple studies\",\n      \"pmids\": [\"15201869\", \"15169877\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for 7SK-induced conformational change in HEXIM1 was unknown\", \"Exact contact surface on CDK9/cyclin T1 was not mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mouse HEXIM1 knockout revealed an essential developmental role: loss of HEXIM1 causes prenatal lethality with cardiac hypertrophy and downregulation of HAND1, establishing HEXIM1 as indispensable for normal cardiovascular development.\",\n      \"evidence\": \"Gene knockout in mice with cardiac phenotype, electron microscopy, Northern blot\",\n      \"pmids\": [\"15172687\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cardiac phenotype is solely due to deregulated P-TEFb was untested\", \"HEXIM2 compensation in heart was not assessed\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Determination that the large P-TEFb complex contains a HEXIM1 homodimer (via coiled-coil domain) bridging two P-TEFb molecules, and that HEXIM2 can functionally compensate for HEXIM1 loss, revealed the precise stoichiometry and redundancy safeguarding P-TEFb regulation.\",\n      \"evidence\": \"Glycerol gradient sedimentation, stoichiometry analysis, mutagenesis, HEXIM1 knockdown with HEXIM2 compensation assays\",\n      \"pmids\": [\"15965233\", \"15713661\", \"15713662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals determining HEXIM1 vs. HEXIM2 usage were unclear\", \"Whether heterodimers have distinct regulatory properties was untested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Biophysical characterization of the cyclin T-binding domain and the discovery that HIV-1 Tat competes with HEXIM1 for cyclin T1 binding defined the molecular basis for P-TEFb hijacking during HIV transcription activation.\",\n      \"evidence\": \"GST pull-down, ITC, fluorescence spectroscopy, analytical gel filtration, HeLa functional assays\",\n      \"pmids\": [\"15855166\", \"15941832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural detail of the Tat–cyclin T1–HEXIM1 competition interface was lacking\", \"Whether GR interaction competes with P-TEFb binding was not fully resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of a HEXIM1–glucocorticoid receptor complex independent of 7SK/P-TEFb established that HEXIM1 has functions beyond P-TEFb inhibition, acting as a direct nuclear receptor coregulator.\",\n      \"evidence\": \"Co-IP, domain mapping, siRNA knockdown, antisense-mediated 7SK disruption\",\n      \"pmids\": [\"15941832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological significance of HEXIM1–GR interaction in glucocorticoid target tissues was not established\", \"Mechanism by which HEXIM1 displaces TIF2 from GR was unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Mapping distinct 7SK RNA elements for HEXIM1 and P-TEFb binding (5' hairpin for HEXIM1, 3' hairpin for P-TEFb) established that HEXIM1 binding to the 5' element is a prerequisite for P-TEFb loading onto the 3' element, explaining hierarchical snRNP assembly.\",\n      \"evidence\": \"Systematic 7SK mutagenesis, in vivo RNA-protein binding assays, minimal RNA reconstitution\",\n      \"pmids\": [\"16382153\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contributions of LARP7 and MePCE to this hierarchical assembly were unknown\", \"Whether the two 7SK elements communicate allosterically was untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The NMR structure of the HEXIM1 cyclin T-binding domain revealed a parallel coiled-coil homodimer with an electrostatic binding interface for cyclin T1, and photo-cross-linking showed that HEXIM1 F208 directly contacts the CDK9 activation segment, establishing a dual-contact inhibition mechanism blocking both cyclin T and CDK9 substrate access.\",\n      \"evidence\": \"NMR solution structure, NMR titration, fluorescence, mutagenesis; site-specific photo-cross-linking in live cells and reconstituted complexes with MS identification\",\n      \"pmids\": [\"17724342\", \"27791144\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full atomic-resolution structure of the entire 7SK–HEXIM1–P-TEFb complex was lacking\", \"Whether HEXIM1 also contacts CDK9 outside the activation segment was unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstration that HIV-1 Tat directly displaces HEXIM1 from preformed 7SK snRNP in vitro and in primary lymphocytes, and that Akt-mediated HEXIM1 phosphorylation independently releases P-TEFb, established two distinct molecular routes for P-TEFb activation relevant to HIV latency reversal.\",\n      \"evidence\": \"In vitro competition with purified proteins, glycerol gradients, PI3K/Akt inhibitors, phosphorylation-resistant HEXIM1 mutants, primary cell analysis\",\n      \"pmids\": [\"17341462\", \"17576689\", \"17937499\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific Akt phosphorylation site on HEXIM1 was not mapped in this study\", \"Relative contribution of Tat displacement vs. phosphorylation during actual HIV infection was unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Insertional mutagenesis confirmed HEXIM1's cardiac essentiality and identified VEGF as a direct transcriptional target, showing HEXIM1 attenuates C/EBPα-mediated repression of VEGF, linking P-TEFb regulation to coronary vascularization.\",\n      \"evidence\": \"Mouse insertional mutation, PECAM-1 staining, ChIP at VEGF promoter, qRT-PCR\",\n      \"pmids\": [\"18079413\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HEXIM1 regulation of VEGF is P-TEFb-dependent or through the C/EBPα mechanism alone was unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that hypertrophic stimuli trigger HEXIM1 dissociation from P-TEFb via JAK/STAT signaling in cardiomyocytes connected P-TEFb reactivation to pathological cardiac hypertrophy.\",\n      \"evidence\": \"Co-IP in primary cardiomyocytes, mechanical stretch, endothelin-1, JAK2 inhibitor AG490\",\n      \"pmids\": [\"17459355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct JAK2 target (HEXIM1 itself or an intermediary) was not identified\", \"Whether this mechanism operates in vivo during heart failure was untested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of LARP7 as the constitutive 7SK snRNP scaffold, with HEXIM1 and P-TEFb as reversible components, clarified the dynamic architecture of the snRNP and explained how 7SK stability is maintained independently of P-TEFb occupancy.\",\n      \"evidence\": \"Immunodepletion, glycerol gradient sedimentation, siRNA knockdown, Tat transactivation assays\",\n      \"pmids\": [\"18281698\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"MePCE's role relative to LARP7 in snRNP stability was not fully addressed\", \"Whether HEXIM1 can exist as a stable 7SK-bound intermediate without P-TEFb in vivo was debated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Nucleophosmin (NPM) was identified as a negative regulator that binds HEXIM1 and promotes its proteasomal degradation; the AML-associated cytoplasmic NPMc+ mutant sequesters HEXIM1, providing a disease mechanism linking HEXIM1 inactivation to leukemogenesis.\",\n      \"evidence\": \"Reciprocal co-IP, GST pull-down, proteasome inhibitor rescue, subcellular fractionation with NPMc+ mutant\",\n      \"pmids\": [\"18371977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ubiquitin ligase responsible for NPM-induced HEXIM1 degradation was not identified\", \"In vivo relevance in AML patient samples was not shown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"NMR revealed that HEXIM1 ARM binding induces opening of the GAUC motif in 7SK's 5' hairpin, and that P-TEFb release by Tat/Brd4 causes a major 7SK conformational change blocking HEXIM1 re-association, establishing HEXIM1 reincorporation as the rate-limiting step of snRNP reassembly.\",\n      \"evidence\": \"NMR spectroscopy of 7SK–ARM complex, SHAPE/DMS probing of released 7SK, in vitro release assays from immunopurified snRNP\",\n      \"pmids\": [\"20675720\", \"20808803\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Factor(s) responsible for resetting 7SK conformation to allow HEXIM1 rebinding were unknown\", \"Whether the conformational switch operates identically for HEXIM2 was untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"PKC phosphorylation of HEXIM1 at S158 was shown to abolish 7SK binding and P-TEFb inhibition, defining a direct signaling mechanism for P-TEFb activation downstream of TCR engagement.\",\n      \"evidence\": \"In vitro kinase assay, S158A phospho-resistant mutant, T cell activation assays, glycerol gradients\",\n      \"pmids\": [\"22821562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other kinases also target S158 was not excluded\", \"Phosphatase(s) reversing S158 phosphorylation were not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"HEXIM1 was shown to stabilize p53 by directly binding its C-terminus and preventing HDM2-mediated ubiquitination, establishing a P-TEFb-independent tumor suppressor function.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, siRNA knockdown, cell cycle analysis in multiple cancer cell lines\",\n      \"pmids\": [\"22948151\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HEXIM1–p53 interaction occurs in the context of 7SK snRNP or free HEXIM1 was unclear\", \"In vivo tumor suppression via p53 stabilization was not directly tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"PPM1G phosphatase was found to bind both 7SK and HEXIM1 after P-TEFb release, blocking snRNP reassembly to sustain NF-κB transcription elongation under ATM kinase control, revealing a regulated 'lock' on the disassembled state.\",\n      \"evidence\": \"Direct in vitro binding assays, ChIP kinetics, ATM inhibition experiments\",\n      \"pmids\": [\"26324325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"PPM1G's phosphatase substrates relevant to this locking mechanism were not identified\", \"Whether PPM1G competes with HEXIM1 for the same 7SK binding site was unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Nucleotide stress was shown to induce HEXIM1 to suppress transcription at tumorigenic loci; HEXIM1 overexpression suppressed melanoma in zebrafish while its loss accelerated tumor onset, providing direct genetic evidence for HEXIM1 as a tumor suppressor.\",\n      \"evidence\": \"Zebrafish gain/loss-of-function melanoma model, RNA immunoprecipitation, human melanoma cell knockdown\",\n      \"pmids\": [\"27058786\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity and mechanism of anti-tumorigenic RNAs stabilized by HEXIM1 were not fully characterized\", \"Whether the tumor-suppressive effect requires P-TEFb inhibition specifically was not dissected\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Discovery of the HDP-RNP complex (HEXIM1–NEAT1–DNA-PK–paraspeckle proteins) and its role in cGAS-STING-IRF3 innate immune signaling revealed a major P-TEFb-independent function: HEXIM1 scaffolds an RNA-dependent complex that senses foreign DNA and activates interferon responses.\",\n      \"evidence\": \"IP/MS, RNA-seq, siRNA knockdown, cGAS-STING pathway activation assays\",\n      \"pmids\": [\"28712728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HEXIM1's RNA-binding specificity for NEAT1 vs. 7SK determines partitioning between P-TEFb and HDP-RNP functions was unclear\", \"Structural basis of HDP-RNP assembly was unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"KDM5B was identified as a direct transcriptional repressor of HEXIM1 via H3K4 demethylation at its promoter; KDM5B inhibition upregulates HEXIM1 and suppresses breast tumor metastasis, defining an epigenetic input controlling HEXIM1 expression in cancer.\",\n      \"evidence\": \"Chemical proteomics, SPR, ChIP at HEXIM1 promoter, shRNA knockdown, mouse metastasis model\",\n      \"pmids\": [\"31805991\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other KDM5 family members also regulate HEXIM1 was not tested\", \"Therapeutic window of KDM5B inhibition via HEXIM1 induction was not defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the full atomic structure of the 7SK–HEXIM1–P-TEFb ternary complex, the molecular basis for partitioning HEXIM1 between 7SK snRNP and HDP-RNP functions, the identity of E3 ligases controlling HEXIM1 turnover, and how P-TEFb-dependent and -independent tumor suppressor activities of HEXIM1 are coordinated in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of the full ternary inhibitory complex\", \"Mechanism of HEXIM1 allocation between 7SK snRNP and NEAT1-based HDP-RNP is unknown\", \"E3 ligase for HEXIM1 ubiquitination/degradation has not been identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 3, 9, 34]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [1, 2, 5, 17, 18, 19]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [22, 23, 29]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 14, 17]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [5, 24]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [14, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 3, 9, 23, 26, 27]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [24, 25]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 21, 30]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 26, 33]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [28, 29]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [31]}\n    ],\n    \"complexes\": [\n      \"7SK snRNP\",\n      \"HDP-RNP\"\n    ],\n    \"partners\": [\n      \"CDK9\",\n      \"CCNT1\",\n      \"HEXIM2\",\n      \"LARP7\",\n      \"NPM1\",\n      \"TP53\",\n      \"NR3C1\",\n      \"PPM1G\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}